China Knee Cartilage Repair Market Report 2022 to 2030

China Knee Cartilage Repair Market Analysis

$ 3999

China knee cartilage repair market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Major factors contributing to the growth of the global knee cartilage repair market include the area's steadily expanding geriatric population, as well as the rising prevalence of different orthopaedic conditions, neuromuscular disorders, sports injuries, and musculoskeletal diseases. The major key players in this market are B. Braun Melsungen AG, Histogenics Corporation, ISTO Biologics, Inc., Johnson & Johnson (DePuy Synthes), MEDIPOST Co., Ltd., Smith & Nephew plc (Osiris Therapeutics, Inc.), Stryker Corporation, Takeda Pharmaceutical Co. Ltd. (TiGenix N.V.), Vericel Corporation, and Zimmer Biomet.

ID: IN10CNPH322 CATEGORY: Pharmaceuticals GEOGRAPHY: China AUTHOR: Saloni Shah

Buy Now

China Knee Cartilage Repair Market Analysis Summary

China Knee Cartilage Repair Market is valued at around $128 Mn in 2022 and is projected to reach $261.5 Mn by 2030, exhibiting a CAGR of 9.34% during the forecast period 2023-2030.

The knee is the largest joint in the body. Upper and lower bones of the knee are separated by two discs (menisci). The tibia and fibula in the lower leg and the femur in the upper leg are connected by ligaments and tendons. Cartilage is the most common type of connective tissue. Our bones, joints, ears, lungs, noses, and spines all contain it in various shapes and sizes. Our joints' surfaces are covered in cartilage, a flexible connective tissue, which protects them from trauma and maintains smooth joint motion. The residual surface of the tissue is also smoothed during the repair of the knee's damaged cartilage. A successful treatment option for isolated full-thickness cartilage abnormalities in the knee is cartilage repair surgery. To stop long-term osteoarthritis, this technique tries to restore cartilage tissue and function.

Some of the most widely used techniques for regenerating knee cartilage are:

Osteotomies
Knee Replacements, and
Microfractures

Surgical techniques or less frequent surgical procedures such allograft osteochondral transplantation, autologous chondrocyte implantation, and artificial scaffolds may occasionally be required to heal damaged cartilage. Major factors contributing to the growth of the global knee cartilage repair market include the area's steadily expanding geriatric population, as well as the rising prevalence of different orthopaedic conditions, neuromuscular disorders, sports injuries, and musculoskeletal diseases. The major key players in this market are B. Braun Melsungen AG, Histogenics Corporation, ISTO Biologics, Inc., Johnson & Johnson (DePuy Synthes), MEDIPOST Co., Ltd., Smith & Nephew plc (Osiris Therapeutics, Inc.), Stryker Corporation, Takeda Pharmaceutical Co. Ltd. (TiGenix N.V.), Vericel Corporation, and Zimmer Biomet.

Market Dynamics

Market Growth Drivers

Increase in the prevalence of knee disorders, growth in technological advanacement and rise in the number of knee surgeries are the main factors driving Knee Cartilage Repair Market. Moreover, Major factors contributing to the growth of the global knee cartilage repair market include the area's steadily expanding geriatric population, as well as the rising prevalence of different orthopaedic conditions, neuromuscular disorders, sports injuries, and musculoskeletal diseases.

Market Restraints

Although knee arthroplasty is a common treatment, the cost is substantial. Technology advancement and the growing popularity of orthopaedic knee implants with less intrusive procedures are to blame for the expense of knee implants. ACI is pricey and involves the implantation of autologous chondrocytes. The transplantation of osteochondral allografts is a specialised surgery. Due to the high cost of allografts, it is expensive. It starts at about $10,000. Consequently, it is anticipated to impede market expansion.

Competitive Landscape

Key Players

B. Braun Melsungen AG
Histogenics Corporation
ISTO Biologics, Inc.
Johnson & Johnson (DePuy Synthes)
MEDIPOST Co., Ltd.
Smith & Nephew Plc (Osiris Therapeutics, Inc.)
Stryker Corporation
Takeda Pharmaceutical Co. Ltd. (TiGenix N.V.)
Vericel Corporation
Zimmer Biomet

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

sexy Knee Cartilage Repair Market Segmentation

By Products

Cell-Based
Non-Cell-Based

By Cartilage Type

Hyaline Cartilage
Fibrocartilage

By End Users

Hospitals
Specialty clinics
Others

By Applications

Osteoarthritis
Rheumatoid Arthritis
Bone Tumors
Fractures
Osteonecrosis

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.